Three calcium antagonists: a place of everyone in treatment arterial hypertension (ALTERNATIVE study)
Abstract
In some regions of Russia, the prescription of different calcium antagonists by physicians was analyzed. This made it possible to assess their experience and knowledge and to direct ways to further improvements of the quality of care to patients with arterial hypertension. The present-day medical treatment of arterial hypertension in the Russian Federation is mainly determined by the recommendations made by the Russian Society of Hypertension and Russian Scientific Society of Cardiology 2008; however, the choice of a drug should be primarily based on a comprehensive assessment of risk factors available in a patient.
About the Authors
И. Чазова
Российский кардиологический научно-производственный комплекс, Москва
Russian Federation
Russian Federation
Л. Ратова
Российский кардиологический научно-производственный комплекс, Москва
Russian Federation
Russian Federation
References
1. Toyo-Oka T, Nayler W. Third generation calcium entry blockers. Blood Press 1996; 5 (4): 206-8.
2. Диагностика и лечение артериальной гипертензии. Российские рекомендации. Кардиоваск. тер. и проф. 2008; 7 (6). Прил. 2.
3. ESH-ESC Guidelines Committee. 2007 guidelines for the management of arterial hypertension. J. Hypertension 2007; 25: 1105-87.
Review
For citations:
, Three calcium antagonists: a place of everyone in treatment arterial hypertension (ALTERNATIVE study). Systemic Hypertension. 2009;(4):26-28.
Views:
134
Email this article 